Beximco Pharmaceuticals (BXP) Stock Chart & Stock Price History GBX 35 -1.50 (-4.11%) (As of 12/20/2024 10:57 AM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlines Beximco Pharmaceuticals Stock Price Performance 5 Day Performance-2.85%1 Month Performance+4.48%3 Month Performance+59.09%6 Month Performance-11.39%Year-To-Date Performance-15.66%1 Year Performance-14.63% Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now BXP Stock Chart for Sunday, December, 22, 2024 BXP Chart by TradingView Beximco Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024GBX 37.70GBX 35-7.16%GBX 37.70GBX 358,902 shs£156.14 million12/19/2024GBX 36.50GBX 37.70+3.29%GBX 37.70GBX 35106,099 shs£168.18 million12/18/2024GBX 36.03GBX 36.50+1.32%GBX 36.50GBX 36.0364,994 shs£162.83 million12/17/2024GBX 36.50GBX 36.03-1.30%GBX 36.50GBX 36.0364,995 shs£160.71 million12/16/2024GBX 36.50GBX 36.50GBX 37.70GBX 36351 shs£162.83 million12/13/2024GBX 36.50GBX 35-4.11%GBX 36.50GBX 3523,000 shs£156.14 million Get the Latest News and Ratings for BXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024GBX 35GBX 36.50+4.29%GBX 36.50GBX 3520,000 shs£162.83 million12/11/2024GBX 37.70GBX 35-7.16%GBX 37.70GBX 3513,340 shs£156.14 million12/10/2024GBX 36.50GBX 37.70+3.29%GBX 37.86GBX 36.40186,542 shs£168.18 million12/09/2024GBX 36GBX 36.50+1.39%GBX 36.98GBX 36.3827,705 shs£162.83 million12/06/2024GBX 36GBX 36GBX 36.80GBX 368,141 shs£160.60 million12/05/2024GBX 35.50GBX 36+1.41%GBX 36.70GBX 34.7837,663 shs£160.60 million12/04/2024GBX 35.14GBX 35.50+1.02%GBX 36.70GBX 34.7837,663 shs£158.37 million12/03/2024GBX 35.50GBX 35.14-1.01%GBX 36.70GBX 34.78119,346 shs£156.76 million12/02/2024GBX 34.50GBX 35.50+2.90%GBX 36GBX 33.83138,434 shs£158.37 million11/29/2024GBX 33.20GBX 33.67+1.42%GBX 35.89GBX 33.6732,180 shs£150.21 million11/28/2024GBX 34GBX 33.20-2.35%GBX 33.50GBX 33.2028,709 shs£148.11 million11/27/2024GBX 33GBX 34+3.03%GBX 35GBX 33.5029,771 shs£151.68 million11/26/2024GBX 33GBX 33GBX 33.90GBX 33212,773 shs£147.22 million11/25/2024GBX 33.50GBX 33-1.49%GBX 33.75GBX 331.06 million shs£147.22 million11/22/2024GBX 33.50GBX 33.50GBX 34GBX 33266,638 shs£149.45 million11/21/2024GBX 34GBX 33.50-1.47%GBX 34GBX 33.5010,963 shs£149.45 million Related Companies Molten Ventures Stock Chart Prs Reit Stock Chart Pinewood Technologies Group Stock Chart Triple Point Social Housing REIT Stock Chart AdvancedAdvT Stock Chart Saga Stock Chart Aurora Investment Trust Stock Chart Celtic Stock Chart Corero Network Security Stock Chart TClarke Stock Chart Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BXP) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BXP Stock Alerts